Prospero’s homologs, particularly Prox1, have been linked to the progression and metastasis of several types of cancer. Studies have shown that Prox1 can act as either a tumor suppressor or an oncogene, depending on the cellular context and the type of cancer. For instance, Prox1 has been observed to suppress colorectal cancer while promoting the aggressive behavior of hepatocellular carcinoma cells.